Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

New treatment alternative for glaucoma imparted in recent Allergan patent

Feb. 11, 2008

Advanced Cell Technology completes pre-IND meeting with FDA for RPE cell therapy

Feb. 6, 2008

LX-201 granted fast track designation for corneal transplant rejection

Jan. 31, 2008

Recent Merck & Co. patent imparts novel agents for ocular disorders

Jan. 24, 2008

Can-Fite expands studies to further investigate efficacy of CF-101 in treating uveitis

Jan. 18, 2008

Ube and Santen patent claims novel agents for glaucoma

Jan. 15, 2008

NicOx and Pfizer extend ophthalmology collaboration agreement

Jan. 10, 2008

E.U. orphan drug status granted for RdCVF for retinitis pigmentosa

Jan. 9, 2008

Allergan patents novel antiglaucoma agents

Jan. 7, 2008

Pfizer initiates Japanese phase II clinical study of PF-03187207 for glaucoma

Jan. 4, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 16, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Anti-C5aR1 antibodies linked to outcomes in giant cell arteritis
BioWorld Science
More effective glucocorticoid-sparing therapies are needed for the treatment of giant cell arteritis (GCA). Studies found that complement signaling pathways...
Fortvita and Innovent patent new anti-TROP2/B7-H4 ADCs
BioWorld Science
Fortvita Biologics Inc. and Innovent Biologics (Suzhou) Co. Ltd. have jointly reported new antibody-drug conjugates (ADCs) comprising a bispecific antibody or...